Remicade's pending approval for ulcerative colitis raises questions about new high-tech versus older approaches

Remicade's pending approval for ulcerative colitis raises questions about new high-tech versus older approaches.

About 85% of patients with severe disease end up with a colectomy when drugs don't work. But this is changing.

Aminosalicylates. Sulfasalazine, 5-aminosalicylic acid, etc are first-line for mild to moderate disease.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote